^Wang T (February 2003). "The effects of the potassium channel opener minoxidil on renal electrolytes transport in the loop of henle". J. Pharmacol. Exp. Ther. 304 (2): 833–40.
doi:
10.1124/jpet.102.043380.
PMID12538840.
S2CID6948410.
^Rundfeldt C (October 1997). "The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells". European Journal of Pharmacology. 336 (2–3): 243–9.
doi:
10.1016/S0014-2999(97)01249-1.
PMID9384239.
^Main MJ, Cryan JE, Dupere JR, Cox B, Clare JJ, Burbidge SA (August 2000). "Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine". Molecular Pharmacology. 58 (2): 253–62.
doi:
10.1124/mol.58.2.253.
PMID10908292.
S2CID11112809.
^Wang T (February 2003). "The effects of the potassium channel opener minoxidil on renal electrolytes transport in the loop of henle". J. Pharmacol. Exp. Ther. 304 (2): 833–40.
doi:
10.1124/jpet.102.043380.
PMID12538840.
S2CID6948410.
^Rundfeldt C (October 1997). "The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells". European Journal of Pharmacology. 336 (2–3): 243–9.
doi:
10.1016/S0014-2999(97)01249-1.
PMID9384239.
^Main MJ, Cryan JE, Dupere JR, Cox B, Clare JJ, Burbidge SA (August 2000). "Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine". Molecular Pharmacology. 58 (2): 253–62.
doi:
10.1124/mol.58.2.253.
PMID10908292.
S2CID11112809.